Fifth Third Bancorp’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74 Hold
58
﹤0.01% 4273
2025
Q4
$139 Hold
58
﹤0.01% 2610
2025
Q3
$165 Sell
58
-34
-37% -$116 ﹤0.01% 2644
2025
Q2
$347 Buy
+92
New +$362 ﹤0.01% 2514
2022
Q2
Sell
-1,565
Closed -$41K 2709
2022
Q1
$41K Hold
1,565
﹤0.01% 1538
2021
Q4
$62K Hold
1,565
﹤0.01% 1422
2021
Q3
$78K Hold
1,565
﹤0.01% 1263
2021
Q2
$87K Hold
1,565
﹤0.01% 1238
2021
Q1
$73K Hold
1,565
﹤0.01% 1271
2020
Q4
$68K Hold
1,565
﹤0.01% 1263
2020
Q3
$57K Buy
+1,565
New +$53.1K ﹤0.01% 1288

Other funds holding HCAT

Fifth Third Bancorp's HCAT Position: Q1 2026 in Review

Fifth Third Bancorp held its Health Catalyst (HCAT) position steady in Q1 2026 at 58 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #4273.

Fifth Third Bancorp first reported a position in HCAT in Q3 2020 and has held it in 11 quarters since. The position peaked at $87K in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Fifth Third Bancorp held 58 shares of Health Catalyst worth $74 as of Q1 2026.
  • Fifth Third Bancorp left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #4273 holding.
  • Fifth Third Bancorp first reported a position in Health Catalyst in Q3 2020 and has held it in 11 quarters since.
  • Fifth Third Bancorp's Health Catalyst position peaked at $87K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.